Which are the causes of Juvenile polyposis syndrome?

Juvenile polyposis syndrome is a rare, hereditary condition primarily caused by pathogenic variants in the SMAD4 or BMPR1A genes, which regulate cellular growth pathways. These genetic mutations disrupt the body’s ability to control the proliferation of cells in the gastrointestinal tract, leading to the development of multiple hamartomatous polyps.

What are the genetic causes of Juvenile polyposis syndrome?

The primary driver of Juvenile polyposis syndrome is an inherited mutation in one of two specific genes. These genes provide instructions for proteins that act like "traffic signals" for cell division; when these signals are faulty, cells grow uncontrollably. Approximately 20% to 50% of individuals with Juvenile polyposis syndrome have a mutation in SMAD4, while a similar percentage carry mutations in BMPR1A. In some cases, a patient may have a clinical diagnosis of Juvenile polyposis syndrome, but genetic testing fails to identify a mutation, suggesting that other, as-yet-undiscovered genes may play a role.

Is Juvenile polyposis syndrome hereditary?

Yes, Juvenile polyposis syndrome follows an autosomal dominant inheritance pattern. This means that a person only needs to inherit one copy of the mutated gene from one parent to be at risk for the condition. However, it is important to note that about 25% of cases arise from a de novo (spontaneous) mutation, meaning the individual is the first in their family to have Juvenile polyposis syndrome.

Are there environmental or external triggers?

There are no known environmental, dietary, or infectious triggers that cause Juvenile polyposis syndrome. Unlike some cancers where lifestyle factors are significant, this is a strictly genetic condition. The development of polyps is driven by internal biological mechanisms rather than external exposure.

How does current research approach the etiology?

Researchers are actively studying the signaling pathways involved in Juvenile polyposis syndrome to develop targeted therapies. Current research focuses on:

• Identifying additional genes involved in cases where SMAD4 and BMPR1A tests return negative results.


• Understanding the "second hit" hypothesis, where a further somatic mutation in the remaining healthy gene copy triggers rapid polyp growth.


• Exploring molecular markers to predict which patients are at the highest risk for malignant transformation.

Next steps

• Consult with a clinical geneticist to discuss genetic testing and family screening options.


• Connect with the 12 members of the DiseaseMaps.org community who are navigating similar experiences.


• Schedule regular surveillance colonoscopies and endoscopies as recommended by a gastroenterologist.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Juvenile polyposis syndrome.


• Orphanet: Rare disease database entry for Juvenile polyposis syndrome.


• OMIM (Online Mendelian Inheritance in Man): Entry #174900 (Juvenile Polyposis Syndrome).


• National Cancer Institute (NCI) PDQ: Genetics of Colorectal Cancer.